| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4211124 | Respiratory Medicine | 2008 | 6 Pages |
Abstract
SummaryAimsTo review the evidence from Cochrane systematic reviews for the effectiveness of traditional Chinese medicinal (TCM) herbs for treating acute respiratory tract infections (ARTIs) and to discuss the limitations of current clinical trials of TCM.FindingsEvidence from six Cochrane systematic reviews was weak owing to the lack of high-quality TCM trials. Limitations were usually due to biases that influenced the validity of results.ConclusionsTCM is widely used for treating ARTIs. However, none of the identified studies has been well designed or conducted. In this overview, we suggest that clinical trials of TCM for ARTIs need to be re-run in accordance with internationally recognized standards.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Taixiang Wu, Xunzhe Yang, Xiaoxi Zeng, Phillippa Poole,